BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/12/2023 8:16:26 AM | Browse: 115 | Download: 233
 |
Received |
|
2023-03-18 17:30 |
|
Peer-Review Started |
|
2023-03-18 17:32 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-05-09 08:12 |
|
Revised |
|
2023-05-09 19:56 |
|
Second Decision |
|
2023-05-15 03:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-05-15 08:50 |
|
Articles in Press |
|
2023-05-15 08:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-06-01 01:26 |
|
Publish the Manuscript Online |
|
2023-06-12 08:16 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Case Control Study |
| Article Title |
Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Eham Amer Ali, Wassan Nori, Alea Farhan Salman, Taghreed S Saeed Al-Rawi, Ban H Hameed and Raid M Al-Ani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Raid M Al-Ani, MBChB, N/A, Academic Editor, Consultant Physician-Scientist, Full Professor, Researcher, Science Editor, Department of Surgery/Otolaryngology, University of Anbar College of Medicine, University of Anbar College of Medicine, Al-Andalus, No. 41 Street, Ramadi City 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq |
| Key Words |
Early onset preeclampsia; Late-onset preeclampsia; Prediction; Elabela; Preeclampsia; Pregnant women |
| Core Tip |
Preeclampsia (PE) is a worldwide cause of increased maternal and perinatal morbidity; PE is divided into early-onset and late-onset subtypes. The precise pathophysiology of PE is obscured, and currently no treatment exists but to terminate pregnancy. Several researches seek a reliable biomarker to anticipate PE to mitigate its negative effects. Elabela (Ela), a recently discovered peptide hormone secreted by the fetus and human placenta; animal studies confirmed Ela’s critical role in maintaining blood pressure; its deficiency was linked to elevated blood pressure. The purpose of this study was to evaluate the accuracy of Ela in predicting PE based on the time of occurrence. |
| Publish Date |
2023-06-12 08:16 |
| Citation |
Amer Ali E, Nori W, Salman AF, Al-Rawi TSS, Hameed BH, Al-Ani RM. Elabela is a reliable biomarker for predicting early onset preeclampsia: A comparative study. World J Clin Cases 2023; 11(17): 3993-4002 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i17/3993.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i17.3993 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
